AIBN Technologies

AIBN has worked to develop and promote a culture of commercialisation. The institute has worked with UniQuest, The University of Queensland's main commercialisation company, to establish start-up companies based on AIBN discoveries and innovations.

Click here for AIBN's Innovation and Commercial Development team.

 

AIBN Technologies section

Pepfactants™

Pepfactants™ are a new class of surfactants that have the unique property of being able to reversibly stabilize and break emulsions and foams.

TenasiTech Pty Ltd

TenasiTech material has many possible applications in markets where thermoplastic polyurethanes are used.

DendriMed Pty Ltd

DendriMed has developed a nanobiotechnology drug delivery platform technology that combines the advantages of polymers with a dendritic architecture. DendriMed achieves this by combining two nanotechnologies – Polymers and Dendrimers.

Vaxxas

Vaxxas has been set up with a $15 million investment, with the aim of developing a revolutionary new needle-free vaccine delivery system.

On this site

Go to top